Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PBF-999 by Palo BioFarma for Prader-Willi Syndrome (PWS): Likelihood of Approval
PBF-999 is under clinical development by Palo BioFarma and currently in Phase II for Prader-Willi Syndrome (PWS). According to GlobalData,...
PBF-1650 by Palo BioFarma for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
PBF-1650 is under clinical development by Palo BioFarma and currently in Phase I for Atopic Dermatitis (Atopic Eczema). According to...
PBF-680 by Palo BioFarma for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval
PBF-680 is under clinical development by Palo BioFarma and currently in Phase II for Chronic Obstructive Pulmonary Disease (COPD). According...